Clinical trial enrollment and progress in women's health.

摘要

To the Editor: Dr Adler recently commented on the Institute of Medicine recommendations to help foster progress in women's health by increasing the availability of sex-specific data.1 We believe that the best way to guarantee that adequate sex-specific data are acquired and examined is if insurers require such data for coverage of drugs, devices, or other, medical interventions. The Centers for Medicare & Medicaid Services (CMS) should lead the way, both because its funding comes from taxpayers and because many insurers follow their coverage decisions.